Use of bivalirudin, a direct thrombin inhibitor, and its reversal with modified ultrafiltration during heart transplantation in a patient with heparin-induced thrombocytopenia
- 28 February 2005
- journal article
- case report
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 24 (2) , 222-225
- https://doi.org/10.1016/j.healun.2003.11.401
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Heparin-induced thrombocytopenia: a common complication in cardiac transplant recipientsThe Journal of Heart and Lung Transplantation, 2002
- Current agents for the treatment of patients with heparin-induced thrombocytopeniaCurrent Opinion in Pulmonary Medicine, 2002
- Heparin-Induced ThrombocytopeniaChest, 2002
- Heparin-induced thrombocytopenia: an overviewBlood Reviews, 2002
- DanaparoidDrugs, 2002
- Heparin-induced thrombocytopenia: natural history, diagnosis, and managementVascular Medicine, 2001
- Recombinant Hirudin in Clinical PracticeCirculation, 2001
- A Synopsis of the Clinical Uses of ArgatrobanJournal of Thrombosis and Thrombolysis, 2001
- Morphological analysis of microparticle generation in heparin-induced thrombocytopeniaBlood, 2000
- CLINICAL APPLICATION OF ARGATROBAN AS AN ALTERNATIVE ANTICOAGULANT FOR EXTRACORPOREAL CIRCULATIONHematology/Oncology Clinics of North America, 2000